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CLINICAL ARTICLES 
Human Granulocytic Ehrlichiosis in Europe: Clinical and Laboratory Findings 
for Four Patients from Slovenia 
Stanka Lotric-Furlan, Miroslav Petrovec, 
Tatjana Avsic Zupanc, William L. Nicholson, 
John W. Sumner, James E. Childs, and Franc Strle 
From the Department of Infectious Diseases, University Medical Centre, 
and the Institute of Microbiology and Immunology, Medical Faculty, 
University of Ljubljana, Ljubljana, Slovenia; and the Viral and 
Rickettsial Zoonoses Branch, Centers for Disease Control and 
Prevention, Atlanta, Georgia, USA 
Febrile illnesses following a tick bite in patients from Slovenia were evaluated for an ehrlichial 
etiology. A case of acute human granulocytic ehrlichiosis (HGE) was confirmed by seroconversion 
to the HGE agent or molecular identification of ehrlichial organisms. Acute infection with the HGE 
agent was confirmed in four patients. None of the patients had detectable antibodies to the HGE 
agent at their first visit, but polymerase chain reaction analysis was positive for three patients. All 
four patients subsequently seroconverted to the HGE agent as shown by high titers of antibody. 
Clinical features and laboratory findings were similar to those in reports from the United States, 
although the disease course was relatively mild in the Slovenian cases. All patients recovered rapidly 
and without sequelae, although only two received antibiotic therapy (of whom only one was treated 
with doxycycline). HGE is an emerging tick-borne disease in the United States and should now be 
included in the differential diagnosis of febrile illnesses occurring after a tick bite in Europe. 
Human granulocytic ehrlichiosis (HGE) is a tick-bome zoo- 
nosis recently described in the United States that is caused by 
an Ehrlichia species closely related or conspecific to the known 
animal pathogens Ehrlichia phagocytophila and Ehrlichia equi 
[1]. In the United States, white-tailed deer and small mammals 
may serve as primary reservoirs of the HGE agent, and the 
tick Ixodes scapularis has been shown to be a competent vec- 
tor [2-5]. 
The presence of antibodies to Ehrlichia antigens has been 
documented in sera from individuals from Switzerland [6], the 
United Kingdom [7], Italy [8], Norway [9], and Sweden [10]. 
However, clinical description of acute HGE in Europe is lim- 
ited to a single case documented in June 1996 in Slovenia [11]. 
Slovenia is a region in which several tick-bome diseases are 
endemic. The annual incidence of tick-bome encephalitis and 
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Lyme borreliosis, both transmitted by Ixodes ricinus ticks, in 
Slovenia is among the highest in Europe [12, 13]. However, 
each summer, numerous patients develop a febrile illness after 
a tick bite for which an etiology has never been established. 
The aim of this prospective study was to determine if infec- 
tion with an Ehrlichia species was associated with febrile ill- 
nesses occurring after a tick bite. Herein we report the clinical 
presentation and laboratory confirmation of the first four con- 
secutive cases of HGE occurring outside of the United States. 
Patients and Methods 
A study to assess the potential ehrlichial etiology of febrile 
illnesses after a tick bite was conducted at the Department 
of Infectious Diseases, University Medical Centre, Ljubljana, 
Slovenia, between March 1995 and December 1996. Patients 
with a febrile illness were referred for evaluation to our institu- 
tion by primary care physicians; only patients with a history 
of a tick bite in the preceding 6 weeks were eligible for the 
study. Patients were examined at the time of their acute illness 
and 14 days, 6-8 weeks, 6 months, and 12 months later. Sus- 
pected acute cases of HGE were confirmed by seroconversion 
with a minimum fourfold rise in titer of antibody to HGE agent 
antigen or by PCR analysis with subsequent sequencing of the 
amplicons. One patient (no. 1, table 1) has been described 
previously [11]. 
At the first visit, blood samples were obtained for determina- 
tion of a complete blood cell count and serum chemistry profile, 
including concentrations of serum aspartate aminotransferase, 
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Table 1. Demographic characteristics and clinical presentation of four patients with human granulocytic ehrlichiosis in Slovenia. 
Incubation Duration 
Patient Age period* Temperaturet Antibiotic of fever 
no. (y)/sex (d) (?C) Chills Headache Vertigo Nausea Malaise Myalgia Arthralgia Other treatment (d) 
1 70/F 12 40 - + - + + + + Vomiting None 5 
2 59/F 21 41 + + + + + + + - Doxycycline+ 4 
3 43/M 7 40 + + - + + + Dry cough Azithromycin? 9 
4 55/F 30 39.3 - + + + + + + Vomiting None 7 
NOTE. + = present; - = absent. 
* Time from tick bite to the onset of illness. 
tMaximum body temperature recorded. 
Dosage, 100 mg b.i.d. for 12 days; treatment was instituted 2 days after spontaneous defervescence. 
? Dosage, 250 mg b.i.d. on the first day, followed by 250 mg q.d. for the following 4 days; treatment was instituted on the second day of illness by a primary 
physician because of suspicion of atypical pneumonia. 
alanine aminotransferase, serum bilirubin, alkaline phospha- 
tase, lactate dehydrogenase, creatine phosphokinase, and C- 
reactive protein. Clinical laboratory procedures were repeated 
at sequential examinations. Giemsa-stained peripheral blood 
smears were examined by use of light microscopy for the pres- 
ence of ehrlichial morulae within WBCs. 
Acute- and convalescent-phase serum samples were tested 
by use of an indirect immunofluorescence assay (IFA) for the 
presence of specific antibodies to the HGE agent (with use of 
the USG3 strain, which was propagated in HL60 promyelocyte 
cells) [14]. This test uses a polyvalent conjugate (goat antibody 
to human IgG with heavy and light chains) and will detect 
human IgG and any other immunoglobulin classes with similar 
light chains. A similar IFA is also conducted with use of Ehr- 
lichia chaffeensis antigen (MRL Diagnostics, Cypress, CA). 
IgM and IgG antibodies to other tick-bore agents were also 
assessed by IFA for Borrelia burgdorferi sensu lato (whole 
cells of a local isolate ofBorrelia afzelii) and Rickettsia conorii 
(bioMerieux, Lyon, France) or by use of an ELISA kit (Immu- 
nozyme, FSME, Immuno AG, Vienna) for the presence of 
antibody to tick-borne encephalitis virus. 
DNA was extracted from WBCs in the buffy coat and used 
as a template for PCR reactions with 16S rRNA gene primers 
GE9f and GElOr, specific to the E. phagocytophila genogroup 
(E. phagocytophila, E. equi, and the HGE agent) [1], and prim- 
ers HE1 and HE3, specific to E. chaffeensis [15]. These samples 
were also tested with a nested PCR method [16] designed to 
detect E. chaffeensis and members of the E. phagocytophila 
genogroup by amplification of part of the groESL heat shock 
operon. Primers HS1 and HS6 were used in primary PCR 
reactions. Samples (1 /1L) of products of the primary reactions 
were used as a template for nested reactions with primers HS43 
and HS45 [16]. Primers HS43 and HS45 span a 442-bp region 
that includes the intergenic spacer between the groES gene and 
the groEL gene and a 392-bp region of the amino coding 
terminus of the groEL gene. Primers HS43 and HS45 were 
used in the initial PCR testing because they also amplify the 
homologous region of the E. chaffeensis groESL operon. 
A variable region of the Ehrlichia groEL gene was amplified 
in additional nested reactions with use of primers HS43 or 
HSVF (5'-CAATAAGCTCCGTGGTGGCCTTC) paired with 
primer HSVR (5'-CTCAACAGCAGCTCTAGTAGC). The 
nucleotide sequences for primers HSVF and HSVR were not 
reported previously, but the cycling parameters were as pre- 
viously described [16]. Primers HSVF and HSVR span a 
395-bp region of the groEL gene that includes nucleotides 812 
through 1,206 when adenine of the putative groEL translation 
initiation codon is designated nucleotide 1. PCR products were 
separated and detected by electrophoresis in agarose gels con- 
taining ethidium bromide. Amplified bands of DNA were ex- 
cised and purified from the gel for sequencing. Purified PCR 
products were sequenced by using the Prism Ready Reaction 
dideoxy cycle sequencing kit (Applied Biosystems, Foster City, 
CA). Both strands of each product were sequenced with use 
of sets of primers from conserved regions [16]. 
Results 
The diagnosis of acute HGE was confirmed in four patients 
(table 1). Three patients were female, and the mean age of the 
patients was 57 years. All the patients presented between June 
and August 1996 and recalled a tick bite 7 to 30 days before 
the onset of their symptoms. 
Two patients required hospitalization, while two were treated 
as outpatients. In all patients, the highest temperature was 
339.3?C. Fever abated spontaneously in all patients, including 
two who had received no antibiotic therapy and one who was 
treated with doxycycline 2 days after defervescence. With the 
exception of fever, clinical examinations revealed few signifi- 
cant abnormalities: one patient presented with conjunctivitis 
and mildly enlarged cervical lymph nodes, and one had pneu- 
monia that was demonstrated radiographically. This patient (no. 
3, table 2) had clinical characteristics of atypical pneumonia 
and was seronegative at all times for Coxiella burnetii, Chla- 
mydiapneumoniae, Chlamydia psittaci, and Mycoplasma pneu- 
moniae. Rash was not present in any of the patients. In all four 
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Table 2. Summary of initial principal laboratory data and physical examination findings for patients with acute human granulocytic ehrlichiosis 
in Slovenia. 
Laboratory finding 
Physical examination finding 
Day WBC Thrombocyte CRP AST ALT LDH CPK 
Patient of Temperature ESR count* countt level level level level level 
no. illness (?C) Other (mm/h) (x 109/L) (X 109/L) (mg/L) (U/L) (U/L) (U/L) (U/L) 
1 3 39.5 Conjunctivitis, cervical 11 6.0 118 58 30 14 390 240 
lymphadenopathy 
2 6 39.8 - 24 3.4 37 179 38 37 372 60 
3 5 39.0 -t 54 10.9 219 83 100 107 214 120 
4 7 39.3 - 11 1.9 60 12 16 13 209 102 
NOTE. ALT = alanine aminotransferase (normal value, 0-42 U/L); AST = aspartate aminotransferase (0-36 U/L); CPK = creatine phosphokinase (42- 
124 U/L); CRP = C-reactive protein (<5 mg/L); ESR = erythrocyte sedimentation rate (<20 mm/h); LDH = lactate dehydrogenase (140-290 U/L); - = 
absent. 
* Normal value, 4.0-10.0 X 109/L. 
t Normal value, 150-350 X 109/L. 
I During later examinations, pneumonia was demonstrated radiographically. 
patients, the clinical course was favorable: none of them 
died, and no long-term consequences were found during a 
follow-up period of 1 year. 
The most common laboratory abnormalities were an elevated 
concentration of serum C-reactive protein (4 patients), throm- 
bocytopenia (3), elevated liver enzyme levels (3), leukopenia 
(2), and an elevated erythrocyte sedimentation rate (2) (table 
2). Lymphopenia was found in only one patient. This patient 
also had granulocytosis with a marked left shift. None of the 
patients had elevated serum creatinine and blood urea nitrogen 
levels or anemia (data not shown). 
Despite intensive examination, intracytoplasmic morulae 
were not seen in any leukocytes on the blood smears. 
Acute infection with the HGE agent was indicated by sero- 
conversion from a negative titer of antibody (< 1/64) to a high 
titer of polyvalent antibody to HGE agent antigen in all four 
patients (table 3). In addition, patient 2 developed a high titer 
of antibody to E. chaffeensis antigen, and patient 1 had a stand- 
Table 3. Results of PCR analysis and titers of antibody to different tick-transmitted agents for four Slovenian patients tested at different 
times after the onset of HGE. 
PCR analysis* 
Patient no., IFA for IgM/IgG 
day from onset rRNA groESL antibody to IFA for IgG to to IgM/IgG to Borrelia IgG to Rickettsia 
of the illness gene operon HGE agent Ehrlichia chaffeensis TBEV burgdorferi conorii 
1 
3 + + - 128 -/ -/128 
14 - NT 256t 128 NT NT NT 
46 - NT 512 128 /- 128/256 
2 
11 + + - - 
-/+-/- 
24 - NT 1,024 >4,096 NT NT NT 
67 - NT 2,048 1,024 -/+ -/- 
3 
20 - NT 256 - NT NT NT 
54 - NT 256 - -/- -/- 
4 
7 + + - - 
-/- / _ 
20 - NT 512 - NT NT NT 
55 - NT 1,024 - -/- -/- 
NOTE. HGE = human granulocytic ehrlichiosis; IFA = indirect immunofluorescence assay; NT = not tested; TBEV = tick-borne encephalitis virus; + = 
positive; - = negative. 
* With use of GE9f and GElOr primers specific to the HGE agent and groESL nested primers. 
t Reciprocal value of serum dilution. 
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ing titer of antibody to E. chaffeensis antigen. Patient 1 devel- 
oped only IgM antibodies to B. burgdorferi sensu lato. 
PCR analysis with primers GE9f and GElOr generated prod- 
ucts of the predicted molecular size (919 bp) from DNA ex- 
tracted from blood samples from three of four patients that 
were obtained at their first hospital visit. Similar results were 
obtained with PCR analysis with the groESL primers (table 
3). Amplification products were not obtained when material 
collected during the follow-up period was subjected to the same 
PCR assay. No product was observed at any time when primers 
specific to E. chaffeensis were used. 
The nucleotide sequence of the 16S rRNA gene amplicon 
from the agent identified in patient 1 was reported [11] to be 
identical to the original sequence of DNA from the HGE agent 
[1]. Two regions of the groESL operon were amplified and 
sequenced from DNA extracted from blood samples from pa- 
tients 1, 2, and 4. The nucleotide sequences of DNA from the 
HGE agents identified in all three patients were identical to 
one another and to previously reported sequences of DNA from 
the HGE agent that were from the region of the groESL operon 
amplified with primers HS43 and HS45 [16]. Sequences were 
found to be more variable in the region amplified by primers 
HSVF and HSVR in a previous comparison, and there were 
five nucleotide positions in which the sequences of DNA from 
North American and European HGE agents consistently dif- 
fered [ 16]. The sequences of DNA from the HGE agents identi- 
fied in all three Slovenian patients were identical in this variable 
region and were most similar to sequences previously amplified 
from DNA from E. phagocytophila, including sequences of 
PCR products from DNA from E. phagocytophila naturally 
infecting a Swiss horse (100% similarity) and from DNA from 
E. phagocytophila experimentally infecting a goat (99.4%) and 
sheep (99.5%) [16]. 
The sequences of DNA from the HGE agents identified in 
the Slovenian patients matched the sequences of DNA from 
European HGE agents in the five positions in which consistent 
differences were previously detected. A 99.2% similarity to 
sequences of DNA from North American HGE agents, includ- 
ing those identified in two patients, a tick, and a horse, was 
found. Finally, a 1,256-bp region was amplified from DNA 
from the HGE agent identified in patient 2 by using primers 
HS43 and HSVR. This sequence was deposited in GenBank 
(Bethesda, MD; accession number AF033101). The sequence 
of this longer product differed from that of the DNA from the 
HGE agent identified in the Swiss horse by one nucleotide 
(99.9% similarity). Sequence variation at the nucleotide level 
did not change the predicted amino acid sequence for the por- 
tion of the groEL gene included in the PCR products. The 
predicted amino acid sequences were identical for all of these 
sequences. 
Discussion 
To our knowledge, this is the first series of European patients 
with acute HGE to be described. Each patient had received a 
tick bite while in central Slovenia, and none had traveled out- 
side of Slovenia during the indicated incubation period. In this 
region, tick-bore encephalitis and Lyme borreliosis are also 
endemic, and etiologic agents of both infections are transmitted 
by I. ricinus [12, 13]. This species is also known as the vector 
of tick-borne fever due to E. phagocytophila in ruminants in 
Europe [17]. Because I. ricinus is the most widespread tick 
species in this part of Europe, it appears likely that it is a vector 
of the HGE agent in Europe. 
The clinical features of and laboratory parameters for our 
four patients were similar to those reported in cases from the 
United States [18-20]. However, the severity of the illness in 
Slovenia was mild to moderate relative to HGE in some patients 
in the United States, where deaths were reported in two of 41 
cases [19]. In general, all laboratory abnormalities were of 
short duration and had resolved by 14 days after the initial 
presentation. Symptoms abated without the use of antibiotics 
in two patients, and the only patient to receive doxycycline, 
the drug of choice for therapy for HGE [21], was treated after 
defervescence. None of the patients died, and no long-term 
consequences were found during a follow-up of 1 year. 
In our study, acute infection with the HGE agent in three 
patients was confirmed by PCR analysis early in the course 
of illness when IgG antibody could not be detected. Other 
researchers who used the same primers, detected ehrlichial 
DNA in 43% of acute-phase blood samples [19]. Serology for 
IgG was useful for the retrospective confirmation of infection. 
Patient 1 could have been coinfected with B. burgdorferi, al- 
though no clinical signs compatible with early Lyme borreliosis 
were present. Cross-reactive antibodies to B. burgdorferi could 
have resulted from infection with the HGE agent as described 
previously [22]. The findings of a standing titer of antibody to 
E. chaffeensis in one patient and seroconversion to E. chaf- 
feensis in another patient are of potential interest, although dual 
reactivity to E. chaffeensis antigens has been shown in 8% to 
17% of HGE cases in the United States [19, 20]. The possibility 
of additional Ehrlichia species causing human illness in Europe 
has not been ruled out. 
PCR assays targeting the 16S rRNA gene have been useful 
in detecting ehrlichial infections in humans. The E. phagocy- 
tophila genogroup, as defined by the similarities among se- 
quences of the 16S rRNA gene [1], contains several closely 
related and possibly conspecific taxa. In previous reports, only 
three base positions within the 1,433-bp amplified region of 
the 16S rRNA gene allowed differentiation of these previously 
identified species. Thus, we chose to amplify and sequence 
portions of the groESL heat shock operon to provide additional 
resolution. A 395-bp region of the groEL gene from members 
of the E. phagocytophila genogroup has been shown to contain 
a distinct pattern of bases in several positions that has consis- 
tently (to date) separated the sequences into Old World and 
New World groupings [16]. In this study, nucleotide sequences 
for this variable region from DNA from the HGE agents identi- 
fied in three of our patients were identical to each other and 
428 Lotric-Furlan et al. CID 1998;27 (September) 
were similar to other sequences clustering in the Old World 
group. 
This initial study should prompt clinicians and practitioners 
to be aware of the potential for ehrlichial infection in febrile 
patients in Europe. In most of Europe, the main differential 
diagnosis of HGE would be a viral infection, particularly the 
initial phase of tick-bore encephalitis (which has a similar 
clinical presentation and is usually accompanied by leukopenia, 
thrombocytopenia, nd, in some patients, elevated liver enzyme 
levels [23]). 
Although the clinical and laboratory findings in this small 
series of patients may not represent the complete spectrum of 
disease, our findings indisputably demonstrate the presence of 
HGE in Slovenia. HGE should be now included in the differen- 
tial diagnosis of febrile illnesses in European patients present- 
ing during the months when tick bites occur. 
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